- Home
- DARE vs SCOR Comparison
DARE vs SCOR Comparison
Compare DARE & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- SCOR
- Stock Information
- Founded
- DARE N/A
- SCOR 1999
- Country
- DARE United States
- SCOR United States
- Employees
- DARE N/A
- SCOR N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- SCOR Business Services
- Sector
- DARE Health Care
- SCOR Consumer Discretionary
- Exchange
- DARE Nasdaq
- SCOR Nasdaq
- Market Cap
- DARE 31.9M
- SCOR 27.2M
- IPO Year
- DARE N/A
- SCOR 2007
- Fundamental
- Price
- DARE $3.21
- SCOR $7.28
- Analyst Decision
- DARE Strong Buy
- SCOR Buy
- Analyst Count
- DARE 4
- SCOR 3
- Target Price
- DARE $20.33
- SCOR $12.83
- AVG Volume (30 Days)
- DARE 64.6K
- SCOR 37.8K
- Earning Date
- DARE 11-14-2024
- SCOR 11-12-2024
- Dividend Yield
- DARE N/A
- SCOR N/A
- EPS Growth
- DARE N/A
- SCOR N/A
- EPS
- DARE N/A
- SCOR N/A
- Revenue
- DARE $1,881,316.00
- SCOR $356,212,000.00
- Revenue This Year
- DARE $388.48
- SCOR N/A
- Revenue Next Year
- DARE $67.37
- SCOR $3.32
- P/E Ratio
- DARE N/A
- SCOR N/A
- Revenue Growth
- DARE 88.13
- SCOR N/A
- 52 Week Low
- DARE $3.05
- SCOR $4.89
- 52 Week High
- DARE $7.56
- SCOR $20.97
- Technical
- Relative Strength Index (RSI)
- DARE 36.32
- SCOR 60.83
- Support Level
- DARE $3.42
- SCOR $5.16
- Resistance Level
- DARE $4.60
- SCOR $8.99
- Average True Range (ATR)
- DARE 0.32
- SCOR 0.79
- MACD
- DARE -0.09
- SCOR 0.28
- Stochastic Oscillator
- DARE 2.11
- SCOR 58.29
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.